DR. BROOKE GILLETT D.O. NPI 1356538003

NPI Information

  • NPI: 1356538003
  • Provider Name: DR. BROOKE GILLETT, D.O.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3850 S NATIONAL AVE
    SUITE 600
    SPRINGFIELD, MO
    ZIP 65807
  • Phone: (417) 882-4880

Map and Directions

Get Directions

NPI Details

DR. Brooke Gillett, D.O. is a medical oncology internal medicine in Springfield, MO with 22 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Brooke Gillett, D.O. NPI is 1356538003. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: ARIZONA COLLEGE OF OSTEOPATHIC MEDICINE MID WESTERN UNIVERSITY
Graduation Year:2004

The provider's business location address is:

3850 S NATIONAL AVE
SUITE 600
SPRINGFIELD, MO
ZIP 65807-287
Phone: (417) 882-4880
Fax: (417) 882-7843

The NPI 1356538003 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Urinalysis, manual test (HCPCS:81002)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Unclassified drugs (HCPCS:J3490)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)

The enumeration date for this NPI number is 9/26/2007 and was last updated on 5/29/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine5838822-1204UTAHNo
2207RX0202XInternal MedicineMedical Oncology2009008961MISSOURIYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.